Holding(s) in Company

RNS Number : 7375W
Deltex Medical Group PLC
21 August 2015
 

20 August 2015

 

Deltex Medical Group plc

("Deltex Medical", "the Company" or "the Group")

 

Holding(s) in the Company

 

This notification was sent on 20 October 2014 by BlackRock, but due to an administrative error upon receipt it was not processed by the Company until 17 August 2015. BlackRock has confirmed to the Company that the position as stated below remains unchanged.

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Deltex Medical Group PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):



3. Full name of person(s) subject to the
notification obligation:
iii

BlackRock, Inc.

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

17th October 2014

6. Date on which issuer notified:

20th October 2014

7. Threshold(s) that is/are crossed or
reached:
vi, vii

Holding has gone below 5%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0059337583

10,776,297

10,776,297

N/A

N/A

N/A

N/A

Below 5%

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 






Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

N/A

Below 5%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

BlackRock Investment Management (UK) Limited - N/A (Below 5%)


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:

BlackRock Regulatory Threshold Reporting Team

14. Contact name:

Gareth Slade

15. Contact telephone number:

020 7743 2536

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEANPFADPSEEF
UK 100

Latest directors dealings